World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
26028
World Ranking
13249
National Ranking
507

Gabriella Ferrandina publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gabriella Ferrandina sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 632 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gabriella Ferrandina D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gabriella Ferrandina sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gabriella Ferrandina is affiliated with the Catholic University of the Sacred Heart in Italy. The primary field of research is Medicine, with a focus on several related subfields such as Obstetrics and Gynecology, Reproductive Medicine, Epidemiology, Surgery, and Oncology.

The main topics of Gabriella Ferrandina's work include:

  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Cervical Cancer and HPV Research
  • Endometriosis Research and Treatment
  • Uterine Myomas and Treatments
  • Radiomics and Machine Learning in Medical Imaging
  • Colorectal and Anal Carcinomas

Frequent co-authors in Gabriella Ferrandina's research network include:

  • Giovanni Scambia
  • Gabriella Macchia
  • Nicolò Bizzarri
  • Luigi Pedone Anchora
  • Francesco Fanfani

Gabriella Ferrandina has contributed publications to various scientific venues, with a number of papers appearing in:

  • International Journal of Gynecological Cancer
  • Radiotherapy and Oncology
  • European Journal of Surgical Oncology
  • Gynecologic Oncology
  • Annals of Surgical Oncology

Recent notable papers authored include:

  • Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study, 2020, Gynecologic Oncology
  • Enhanced recovery after surgery (ERAS) in gynecology oncology, 2020, European Journal of Surgical Oncology
  • How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study, 2020, Annals of Surgical Oncology
  • Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization, 2023, Vaccines
  • High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes, 2021, Gynecologic Oncology

Best Publications

  • Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.

    A. Bellacosa;D. De Feo;A. K. Godwin;D. W. Bell

  • CLASS III BETA-TUBULIN OVEREXPRESSION IS A PROMINENT MECHANISM OF PACLITAXEL RESISTANCE IN OVARIAN CANCER PATIENTS

    Simona Mozzetti;Cristiano Ferlini;Paola Concolino;Flavia Filippetti

  • A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study.

    Anna Fagotti;Gabriella Ferrandina;Francesco Fanfani;Alfredo Ercoli

  • Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.

    Anna Fagotti;Gabriella Ferrandina;Giuseppe Vizzielli;Francesco Fanfani

  • Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.

    Sandro Pignata;Giovanni Scambia;Dionyssios Katsaros;Ciro Gallo

  • Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target.

    G. Scambia;F. O. Ranelletti;P. Benedetti Panici;R. De Vincenzo

  • Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma.

    M Maurizi;G Almadori;G Ferrandina;M Distefano

  • Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer

    Gabriella Ferrandina;Manuela Ludovisi;Domenica Lorusso;Sandro Pignata

  • Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma.

    Anna Fagotti;Gabriella Ferrandina;Francesco Fanfani;Giorgia Garganese

  • Expression of CD133-1 and CD133-2 in ovarian cancer.

    G. Ferrandina;G. Bonanno;L. Pierelli;A. Perillo

  • Class III β-Tubulin Overexpression Is a Marker of Poor Clinical Outcome in Advanced Ovarian Cancer Patients

    Gabriella Ferrandina;Gian Franco Zannoni;Enrica Martinelli;Amelia Paglia

  • Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging

    L. Savelli;M. Ceccarini;M. Ludovisi;E. Fruscella

  • Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients

    G. Ferrandina;L. Lauriola;M. G. Distefano;G. F. Zannoni

  • Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial

    Sandro Pignata;Giovanni Scambia;Gabriella Ferrandina;Antonella Savarese

  • Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors

    Sergio Rutella;Giuseppina Bonanno;Annabella Procoli;Andrea Mariotti

  • Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells

    Laura Rosanò;Roberta Cianfrocca;Francesca Spinella;Valeriana Di Castro

  • Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients

    G. Ferrandina;L. Lauriola;G. F. Zannoni;A. Fagotti

  • Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.

    Valeria Masciullo;Alessandro Sgambato;Carmen Pacilio;Bruna Pucci

  • Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression.

    Maria Marone;Giovanni Scambia;Cecilia Giannitelli;Gabriella Ferrandina

  • Bcl-2 Down-Regulation Is a Novel Mechanism of Paclitaxel Resistance

    Cristiano Ferlini;Giuseppina Raspaglio;Simona Mozzetti;Mariagrazia Distefano

Frequent Co-Authors

Giovanni Scambia
Giovanni Scambia Catholic University of the Sacred Heart
Salvatore Mancuso
Salvatore Mancuso Catholic University of the Sacred Heart
Domenica Lorusso
Domenica Lorusso Catholic University of the Sacred Heart
Sandro Pignata
Sandro Pignata National Cancer Institute
Francesco Cosentino
Francesco Cosentino Karolinska University Hospital
Pierluigi Benedetti Panici
Pierluigi Benedetti Panici Sapienza University of Rome
Fabio Ghezzi
Fabio Ghezzi University of Insubria
Nicoletta Colombo
Nicoletta Colombo University of Milano-Bicocca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA doesn't always mean earning a traditional MD. Many students consider online degrees in related fields to increase their flexibility, reduce costs, and access growing job markets. For those interested in healthcare management, enrolling in one of the cheapest mha programs online allows you to gain practical leadership skills with minimal financial burden. This route appeals to students who wish to move into hospital administration or healthcare consultancy.

Similarly, those searching for advanced leadership roles can review the cheapest mha online programs for options that balance affordability with high-quality curriculum. Nursing professionals looking to expand their scope may be interested in the cheapest bsn to dnp programs, which provide a fast track from a Bachelor of Science in Nursing to a Doctor of Nursing Practice.

Pharmacy is another in-demand area, and online pharmacy schools are making it easier for students to earn a doctorate degree remotely. These varied pathways can help you enter the medical field, enhance your credentials, and open the door to a wide range of careers beyond a traditional physician’s role.

Best Scientists Citing Gabriella Ferrandina

Trending Scientists

Recently Published Articles